Views & Analysis What doctors say about the EU referendum Daniel Ghinn tunes into the conversation around the EU referendum, which takes place on Thursday
Articles Pharma warns of European exit – but British public needs mor... If there is one thing that big pharma companies hate more than anything, it's uncertainty about the future of their markets and regulations.
News J&J jumps on the MFN pricing train Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
